Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and tolerability of nebivolol compared with carvedilol in patients with coronary artery disease and stage I or II hypertension.

Trial Profile

Efficacy and tolerability of nebivolol compared with carvedilol in patients with coronary artery disease and stage I or II hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2010

At a glance

  • Drugs Nebivolol (Primary) ; Carvedilol
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 05 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 May 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 29 May 2009 Inclusion criteria amended from NCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top